Weiss Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,410
Closed -$359K 735
2025
Q4
$359K Buy
+14,410
New +$363K ﹤0.01% 509
2021
Q3
Sell
-208,797
Closed -$8.18M 591
2021
Q2
$8.18M Buy
+208,797
New +$8.12M 0.2% 142
2020
Q1
Sell
-6,683
Closed -$248K 295
2019
Q4
$248K Sell
6,683
-1,247
-16% -$44.4K 0.02% 207
2019
Q3
$270K Buy
7,930
+2,952
+59% +$107K 0.02% 187
2019
Q2
$205K Hold
4,978
0.01% 241
2019
Q1
$201K Buy
+4,978
New +$199K 0.02% 224

Other funds holding PFE

Weiss Asset Management's PFE Position: Q1 2026 in Review

Weiss Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 14,410 shares — an estimated $359K sold.

Weiss Asset Management first reported a position in PFE in Q1 2019 and held it in 6 quarters. The position peaked at $8.18M in Q2 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Weiss Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Weiss Asset Management sold 14,410 Pfizer shares in Q1 2026, an estimated $359K.
  • Weiss Asset Management first reported a position in Pfizer in Q1 2019 and held it in 6 quarters.
  • Weiss Asset Management's Pfizer position peaked at $8.18M in Q2 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.